CELL-CYCLE INHIBITION BY INDEPENDENT CDK AND PCNA BINDING DOMAINS IN P21(CIP1)

被引:535
作者
LUO, Y
HURWITZ, J
MASSAGUE, J
机构
[1] MEM SLOAN KETTERING CANC CTR,CELL BIOL & GENET PROGRAM,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10021
关键词
D O I
10.1038/375159a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MAMMALIAN cell-cycle control by antimitogenic signals involves p21(Cip1/WAF1) (refs 1-4), p27(Kip1) (refs 5, 6) and p57(Kip2) (refs 7, 8), a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase 6 processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication(9,10). The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.
引用
收藏
页码:159 / 161
页数:3
相关论文
共 19 条
  • [1] IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS
    ATTISANO, L
    CARCAMO, J
    VENTURA, F
    WEIS, FMB
    MASSAGUE, J
    WRANA, JL
    [J]. CELL, 1993, 75 (04) : 671 - 680
  • [2] SEPARATE DOMAINS OF P21 INVOLVED IN THE INHIBITION OF CDK KINASE AND PCNA
    CHEN, JJ
    JACKSON, PK
    KIRSCHNER, MW
    DUTTA, A
    [J]. NATURE, 1995, 374 (6520) : 386 - 388
  • [3] ACTIVATION OF HUMAN CYCLIN-DEPENDENT KINASES INVITRO
    DESAI, D
    GU, Y
    MORGAN, DO
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (05) : 571 - 582
  • [4] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [5] CDK-INTERACTING PROTEIN-1 DIRECTLY BINDS WITH PROLIFERATING CELL NUCLEAR ANTIGEN AND INHIBITS DNA-REPLICATION CATALYZED BY THE DNA-POLYMERASE-DELTA HOLOENZYME
    FLORESROZAS, H
    KELMAN, Z
    DEAN, FB
    PAN, ZQ
    HARPER, PW
    ELLEDGE, SJ
    ODONNELL, M
    HURWITZ, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) : 8655 - 8659
  • [6] INHIBITION OF CDK2 ACTIVITY IN-VIVO BY AN ASSOCIATED 20K REGULATORY SUBUNIT
    GU, Y
    TURCK, CW
    MORGAN, DO
    [J]. NATURE, 1993, 366 (6456) : 707 - 710
  • [7] HARPER JW, 1993, CELL, V75, P805
  • [8] A SHORT AMINO-ACID SEQUENCE ABLE TO SPECIFY NUCLEAR LOCATION
    KALDERON, D
    ROBERTS, BL
    RICHARDSON, WD
    SMITH, AE
    [J]. CELL, 1984, 39 (03) : 499 - 509
  • [9] CYCLIC-AMP-INDUCED G1 PHASE ARREST MEDIATED BY AN INHIBITOR (P27(KIP1)) OF CYCLIN-DEPENDENT KINASE-4 ACTIVATION
    KATO, JY
    MATSUOKA, M
    POLYAK, K
    MASSAGUE, J
    SHERR, CJ
    [J]. CELL, 1994, 79 (03) : 487 - 496
  • [10] KELMAN Z, IN PRESS METH ENZYM